摘要
背景:虽然大麻是最通用的植物物种之一,多用途作为医疗,食品来源和精神活性滥用,其生物医学相关性集中注意力主要大麻素。大麻的植物化学特征突出显示了各种非大麻素组分的存在,包括类黄酮,螺茚满,二氢芪,二氢菲,木脂素,类固醇和生物碱。这篇综述旨在确定这种植物中存在的多酚,它们的生物合成,它们的生物活性和它们的合成。 方法:我们进行了一项系统性研究,重点研究书目数据库,包括各种苜蓿品系中所有非大麻素酚类物质的分离,结构阐明及其合成的生物学活性。 结果:尽管如此,迄今为止关注的仅仅是大麻素(超过一百个单独的大麻素),大麻是一种复杂的植物,能够产生超过480种代表几乎所有不同生物遗传类型的化学实体。关于酚类化合物,植物生物合成了大量独特的非大麻素第二代谢物,如异戊烯化黄酮类化合物,苯乙烯衍生物和木脂素酰胺。 结论:大麻是一种具有高度药理和营养价值的植物,其潜力和应用不仅限于大麻素的生物活性,还由非大麻素化合物定义。其他大麻素与非大麻素成分的组合可以增强THC的有益效果并且可以减少不希望的副作用。
关键词: 非大麻素,抗氧化剂,类黄酮,螺茚满类,木酚素类,大麻苜蓿
Current Medicinal Chemistry
Title:Cannabis Phenolics and their Bioactivities
Volume: 25 Issue: 10
关键词: 非大麻素,抗氧化剂,类黄酮,螺茚满类,木酚素类,大麻苜蓿
摘要: Background: Although Cannabis sativa L. is one of the most versatile plant species with multipurpose use both as medical, alimentary source and as psychoactive abuse, its biomedical relevance focused the attention on major cannabinoids. Phytochemical characterization of cannabis highlights the presence of various non-cannabinoids constituents including flavonoids, spiroindans, dihyrostilbenes, dihydrophenanthrenes, lignanamides, steroids and alkaloids. This review aims to identify polyphenols present in this plant, their biosynthesis, their bioactivities and their synthesis, when this occurred.
Methods: We undertook a systematic research focused on bibliographic databases including all noncannabinoids phenolics in various C. sativa strains from their isolation, structural elucidation, their biological activity to their synthesis.
Result: Nevertheless, attention has so far been focused only on cannabinoids (more than one hundred isolated), cannabis is a complex plant able to produce more than 480 chemical entities that represent almost all of the different biogenetic classes. Regarding phenolic compounds, the plant biosynthesises a plethora of unique non-cannabinoids second metabolites, such as prenylated flavonoids, stilbenoids derivatives and lignanammides.
Conclusion: Cannabis is a plant with high pharmacological and nutrition values, its potentialities and applications are not only circumscribed to cannabinoids biological activities, but also defined by noncannabinoid compounds. The combination of other cannabinoids together with noncannabinoid components could enhance the beneficial effects of THC and could reduce undesirable side effects.
Export Options
About this article
Cite this article as:
Cannabis Phenolics and their Bioactivities, Current Medicinal Chemistry 2018; 25 (10) . https://dx.doi.org/10.2174/0929867324666170810164636
DOI https://dx.doi.org/10.2174/0929867324666170810164636 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antineoplastic Potential of Medicinal Plants
Recent Patents on Biotechnology Recent Progress in the Development of Anticancer Agents
Current Medicinal Chemistry - Anti-Cancer Agents Lipoidal-Nano Architecture for Parental Drug Delivery: Formulation Development and Regulatory Concerns
Current Applied Polymer Science Epigenetic Regulation and Therapeutic Approaches in Cancer
Current Topics in Medicinal Chemistry Synthesis and Evaluation of New Thiazolyl Hydrazone Derivatives as Potential Anticancer Agents
Letters in Drug Design & Discovery Sporadic Porphyria in a Patient with Stage II Melanoma Treated with Interferon α
Current Drug Safety Pharmacological Activation of Protein Phosphatase 2 A (PP2A): A Novel Strategy to Fight Against Human Malignancies?
Current Medicinal Chemistry Function of miRNA in Controlling Drug Resistance of Human Cancers
Current Drug Targets Cytotoxic T Cell Reponses Against Immunoglobulin in Malignant and Normal B Cells: Implications for Tumor Immunity and Autoimmunity
Current Pharmaceutical Design Germinal and Somatic Trisomy 21 Mosaicism: How Common is it, What are the Implications for Individual Carriers and How Does it Come About?
Current Genomics Discovering Tumor Suppressor Genes Through Genome-Wide Copy Number Analysis
Current Genomics Rhein Derivatives, A Promising Pivot?
Mini-Reviews in Medicinal Chemistry Targeting the mTOR Pathway in Tumor Malignancy
Current Cancer Drug Targets Small Molecule Tyrosine Kinase Inhibitors: The New Dawn for Cancer Therapy
Letters in Drug Design & Discovery Molecular Dynamics and Structural Studies of the Ets Domain-DNA Complexes
Current Bioinformatics Rheumatic Manifestations in Malignancy
Current Rheumatology Reviews Bruton Kinase Inhibitors in Chronic Lymphocytic Leukemia
Anti-Cancer Agents in Medicinal Chemistry Cyclin-Dependent Kinase as a Novel Therapeutic Target: An Endless Story
Current Chemical Biology The Role of ING Tumor Suppressors in UV Stress Response and Melanoma Progression
Current Drug Targets Synthesis and Anticancer Activity of Phthalimido and Naphthalimido Substituted Dihydropyrimidone Conjugates
Letters in Drug Design & Discovery